Towards automating risk stratification of intraductal papillary mucinous Neoplasms: Artificial intelligence advances beyond human expertise with confocal laser endomicroscopy

迈向导管内乳头状黏液性肿瘤风险分层自动化:人工智能与共聚焦激光内镜技术超越人类专业知识

阅读:2

Abstract

BACKGROUND AND AIMS: Endoscopic Ultrasound (EUS)-guided needle-based confocal laser endomicroscopy (nCLE) enables real-time microscopic visualization of pancreatic cyst epithelium and can identify high-grade dysplasia/invasive adenocarcinoma (HGD/IC) in branch-duct (BD) intraductal papillary mucinous neoplasms (IPMNs). We aimed to compare the performance of experts (humans) with artificial intelligence (AI) in stratifying dysplasia in BD-IPMNs. METHODS: This post-hoc analysis involved BD-IPMNs with definitive diagnoses from prospective EUS-nCLE studies (2015-2023) enrolled at a single center. Dysplasia grade was reviewed by two pathologists. Blinded EUS-nCLE experts reviewed unedited nCLE videos to classify dysplasia without and with revised Fukuoka criteria (revised-FC). The AI model, nCLE-AI, was similarly analyzed. Diagnostic parameters and AUC were compared to evaluate human and nCLE-AI performance. RESULTS: Among 60 BD-IPMNs (mean size = 3.43 ± 1.00 cm), 23 (38.3 %) had HGD/IC. To detect HGD/IC using nCLE, interobserver agreement (IOA) among 16 nCLE experts was 'fair' (κ = 0.29, 95 % CI: 0.27-0.32), with a sensitivity of 58 %, specificity of 59 %, and AUC of 0.59 (95 % CI 0.55-0.62). Incorporating revised-FC improved the sensitivity to 72 % and AUC to 0.64 (95 % CI 0.61-0.68; p < 0.001), with similar IOA (κ = 0.36 'fair', 95 % CI: 0.33-0.38) and specificity (57 %). Comparatively, nCLE-AI achieved 87 % sensitivity, 54 % specificity, and an AUC of 0.70 (0.57-0.84). When combined with revised-FC, nCLE-AI reached 78 % sensitivity, 78 % specificity, and an AUC of 0.85 (95 % CI: 0.74-0.96, p = 0.02), significantly higher than humans with revised-FC (p < 0.01). CONCLUSIONS: Human dysplasia classification of BD-IPMNs using nCLE showed modest IOA and accuracy. In contrast, nCLE-AI classifications combined with clinical criteria offer superior accuracy for detecting HGD/IC while eliminating interobserver variability.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。